AcerMed goes belly-up, president points to lawsuit

TriMed Staff | | Health Imaging | Artificial Intelligence

AcerMed, an ambulatory EMR provider in Irvine, California, has gone out of business, and its president, Richard Younis, blames a lawsuit with MedInformatix for the company's demise.

AcerMed had been entangled in a legal dispute with MedInformatix, a Los Angeles-based health IT provider, who alleged that AcerMed stole its software code. AcerMed was fined, but not found in copyright violation. The ruling is currently under appeal.

In an interview with EMR Update, Yonis said the lawsuit drained the company of its resources and prevented it from securing additional funding.

In AcerMed’s final release on Sept. 5, it addressed its customers in an unsigned letter: “Meanwhile, if you need product support you may contact some of our former employees who are willing to work with you independent of AcerMed support purposes, on a best effort basis."

AcerMed may be the first company with a CCHIT-certified product to collapse.

TriMed Staff

Related Content

AI needle-path generation slashes insertions times for CT-guided biopsies
Prompts matter: How input elements affect large language model performance
AI can help radiology standardize image exam data labeling
Mayo Clinic and Microsoft partner to advance generative AI in radiology
ACR partners to create AI foundational model assessment website
Could synthetic images replace the need for contrast?

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.